M1-polarized macrophage-derived cellular nanovesicle-coated lipid nanoparticles for enhanced cancer treatment through hybridization of gene therapy and cancer immunotherapy
Optimum genetic delivery for modulating target genes to diseased tissue is a major obstacle for profitable gene therapy. Lipid nanoparticles (LNPs), considered a prospective vehicle for nucleic acid delivery, have demonstrated efficacy in human use during the COVID-19 pandemic. This study introduces...
Saved in:
Main Authors: | Ha Eun Shin (Author), Jun-Hyeok Han (Author), Seungyong Shin (Author), Ga-Hyun Bae (Author), Boram Son (Author), Tae-Hyung Kim (Author), Hee Ho Park (Author), Chun Gwon Park (Author), Wooram Park (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Concurrent immune checkpoint blockade for enhanced cancer immunotherapy utilizing engineered hybrid nanovesicles
by: Yuxuan Liu, et al.
Published: (2024) -
Recent advances in the liposomal nanovesicles based immunotherapy in the treatment of cancer: A review
by: Yahya Alhamhoom, et al.
Published: (2023) -
Investigations on Cellular Uptake Mechanisms and Immunogenicity Profile of Novel Bio-Hybrid Nanovesicles
by: Yi-Hsuan Ou, et al.
Published: (2022) -
Ethyl Acetate Fraction of Adenophora triphylla var. japonica Inhibits Migration of Lewis Lung Carcinoma Cells by Suppressing Macrophage Polarization toward an M2 Phenotype
by: Shin-Hyung Park
Published: (2019) -
PD-1 Cellular Nanovesicles Carrying Gemcitabine to Inhibit the Proliferation of Triple Negative Breast Cancer Cell
by: Hualian Zha, et al.
Published: (2022)